Preclinical pharmacology of the novel oral dual histamine H1 and H3 receptor antagonist GSK835726

被引：0
|
作者：
Ford, A. [1 ]
Browning, C. [1 ]
Russell, L. [1 ]
Saunders, K. [1 ]
Hall, D. [1 ]
Morrison, V [1 ]
Changani, K. [1 ]
Hodgson, S. [2 ]
Connor, H. [1 ]
Clark, K. [1 ]
机构：
[1] GlaxoSmithKline R&D, Resp Biol, Stevenage, Herts, England
[2] GlaxoSmithKline R&D, Med Chem, Stevenage, Herts, England
来源：
ALLERGY | 2009年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
145
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [1] Preclinical pharmacology of the novel intranasal dual histamine H1 and H3 receptor antagonist GSK1004723
    Clark, K.
    Russell, L.
    Hall, D.
    Luttmann, M.
    Ford, A.
    Saunders, K.
    Changani, K.
    Hodgson, S.
    Connor, H.
    Browning, C.
    ALLERGY, 2009, 64 : 129 - 129
  • [2] Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine
    Aslanian, R
    Mutahi, MW
    Shih, NY
    Piwinski, JJ
    West, R
    Williams, SM
    She, S
    Wu, RL
    Hey, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (12) : 1959 - 1961
  • [3] Design and synthesis of novel dual histamine H1/H3 receptor antagonists based on the H1 receptor antagonist chlorpheniramine.
    Aslanian, R
    Mutahi, MW
    Tom, W
    Shih, NY
    Piwinski, JJ
    West, R
    Williams, SM
    She, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A98 - A98
  • [4] Design and synthesis of novel dual histamine H1/H3 receptor antagonists based on the H1 and H3 pharmacophore.
    Shih, NY
    Solomon, D
    Schwerdt, J
    Conn, D
    Tom, W
    Orlando, S
    Aslanian, R
    Piwinski, JJ
    West, R
    She, S
    Williams, SM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A98 - A98
  • [5] Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040
    Eric Southam
    Jackie Cilia
    Jane E. Gartlon
    Marie L. Woolley
    Laurent P. Lacroix
    Carol A. Jennings
    Jane E. Cluderay
    Charlie Reavill
    Claire Rourke
    David M. Wilson
    Lee A. Dawson
    Andrew D. Medhurst
    Declan N. C. Jones
    Psychopharmacology, 2009, 201 : 483 - 494
  • [6] Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040
    Southam, Eric
    Cilia, Jackie
    Gartlon, Jane E.
    Woolley, Marie L.
    Lacroix, Laurent P.
    Jennings, Carol A.
    Cluderay, Jane E.
    Reavill, Charlie
    Rourke, Claire
    Wilson, David M.
    Dawson, Lee A.
    Medhurst, Andrew D.
    Jones, Declan N. C.
    PSYCHOPHARMACOLOGY, 2009, 201 (04) : 483 - 494
  • [7] Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H1 and H3 receptors
    Slack, R. J.
    Russell, L. J.
    Hall, D. A.
    Luttmann, M. A.
    Ford, A. J.
    Saunders, K. A.
    Hodgson, S. T.
    Connor, H. E.
    Browning, C.
    Clark, K. L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (06) : 1627 - 1641
  • [8] A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor
    Suzuki, Keiko
    Morokata, Tatsuaki
    Morihira, Koichiro
    Sato, Ippei
    Takizawa, Satoko
    Kaneko, Masayuki
    Takahashi, Koichiro
    Shimizu, Yasuaki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 563 (1-3) : 224 - 232
  • [9] GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models
    Medhurst, Andrew D.
    Atkins, Alan R.
    Beresford, Isabel J.
    Brackenborough, Kim
    Briggs, Michael A.
    Calver, Andrew R.
    Cilia, Jackie
    Cluderay, Jane E.
    Crook, Barry
    Davis, John B.
    Davis, Rebecca K.
    Davis, Robert P.
    Dawson, Lee A.
    Foley, Andrew G.
    Gartlon, Jane
    Gonzalez, M. Isabel
    Heslop, Teresa
    Hirst, Warren D.
    Jennings, Carol
    Jones, Declan N. C.
    Lacroix, Laurent P.
    Martyn, Abbe
    Ociepka, Sandrine
    Ray, Alison
    Regan, Ciaran M.
    Roberts, Jennifer C.
    Schogger, Joanne
    Southam, Eric
    Stean, Tania O.
    Trail, Brenda K.
    Upton, Neil
    Wadsworth, Graham
    Wald, Jeffrey A.
    White, Trevor
    Witherington, Jason
    Woolley, Marie L.
    Worby, Angela
    Wilson, David M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (03): : 1032 - 1045
  • [10] Histamine H3 receptor antagonist-induced pruritus can be inhibited by blockade of histamine H1 and H4 receptors
    Rossbach, K.
    Stark, H.
    Sander, K.
    Kietzmann, M.
    Baeumer, W.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2009, 32 : 220 - 220
12345